MIR4261: A Drug Target / Disease Biomarker (G100422929)

MIR4261: A Drug Target / Disease Biomarker

MIR4261, also known as interleukin-4 dependent gene 11, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

MIR4261 is a key regulator of the interleukin-4 (IL-4) signaling pathway, which plays a crucial role in the regulation of immune and inflammatory responses. IL-4 is a cytokine that is involved in the development and maintenance of tissues and organs, and is implicated in a wide range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

MIR4261 has been shown to be involved in the regulation of IL-4 signaling by interacting with the protein STAT3, which is a key regulator of IL-4 signaling. MIR4261 has been shown to physically interact with STAT3 and to regulate the activity of STAT3. This interaction between MIR4261 and STAT3 has been shown to play a role in the regulation of immune responses and the development of autoimmune disorders.

In addition to its role in IL-4 signaling, MIR4261 has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs, including cell growth, apoptosis, and angiogenesis.

MIR4261 has been shown to be involved in the regulation of cell growth by interacting with the protein p21, which is a negative regulator of cell growth. MIR4261 has been shown to physically interact withp21 and to regulate the activity ofp21. This interaction between MIR4261 andp21 has been shown to play a role in the regulation of cell growth and the development of cancer.

MIR4261 has also been shown to be involved in the regulation of apoptosis, which is the process by which cells die and are removed from the body. MIR4261 has been shown to interact with the protein Bcl-2, which is a protein that plays a role in the regulation of apoptosis. MIR4261 has been shown to physically interact with Bcl-2 and to regulate the activity of Bcl-2. This interaction between MIR4261 and Bcl-2 has been shown to play a role in the regulation of apoptosis and the development of neurodegenerative diseases.

In addition to its role in cell growth and apoptosis, MIR4261 has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body. MIR4261 has been shown to interact with the protein VEZNA, which is a protein that plays a role in the regulation of angiogenesis. MIR4261 has been shown to physically interact with VEZNA and to regulate the activity of VEZNA. This interaction between MIR4261 and VEZNA has been shown to play a role in the regulation of angiogenesis and the development of diseases that involve inflammation or ischemia.

MIR4261 has also been shown to be involved in the regulation of inflammation and immune responses. MIR4261 has been shown to interact with the protein NF-kappa-B, which is a protein that plays a role in the regulation of inflammation and immune responses. MIR4261 has been shown to physically interact with NF-kappa-B and to regulate the activity of NF-kappa-B. This interaction between MIR4261 and NF-kappa-B has been shown to play

Protein Name: MicroRNA 4261

The "MIR4261 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4261 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443